DK1105498T3 - HIV vaccine - Google Patents

HIV vaccine

Info

Publication number
DK1105498T3
DK1105498T3 DK99938094T DK99938094T DK1105498T3 DK 1105498 T3 DK1105498 T3 DK 1105498T3 DK 99938094 T DK99938094 T DK 99938094T DK 99938094 T DK99938094 T DK 99938094T DK 1105498 T3 DK1105498 T3 DK 1105498T3
Authority
DK
Denmark
Prior art keywords
hiv vaccine
vaccine
hiv
Prior art date
Application number
DK99938094T
Other languages
Danish (da)
English (en)
Inventor
Chil-Yong Kang
Yan Li
Original Assignee
Univ Western Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Western Ontario filed Critical Univ Western Ontario
Application granted granted Critical
Publication of DK1105498T3 publication Critical patent/DK1105498T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK99938094T 1998-08-12 1999-08-12 HIV vaccine DK1105498T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9623598P 1998-08-12 1998-08-12
PCT/CA1999/000746 WO2000009703A1 (en) 1998-08-12 1999-08-12 Hiv vaccine

Publications (1)

Publication Number Publication Date
DK1105498T3 true DK1105498T3 (da) 2009-08-31

Family

ID=22256483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99938094T DK1105498T3 (da) 1998-08-12 1999-08-12 HIV vaccine

Country Status (14)

Country Link
EP (1) EP1105498B1 (zh)
KR (1) KR100689249B1 (zh)
CN (1) CN1206355C (zh)
AP (1) AP1561A (zh)
AT (1) ATE431415T1 (zh)
AU (1) AU5274099A (zh)
CA (1) CA2339850C (zh)
DE (1) DE69940886D1 (zh)
DK (1) DK1105498T3 (zh)
ES (1) ES2327300T3 (zh)
OA (1) OA11598A (zh)
PT (1) PT1105498E (zh)
WO (1) WO2000009703A1 (zh)
ZA (1) ZA200100941B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608273B2 (en) * 1998-08-12 2009-10-27 University Of Western Ontario Recombinant lentivirus encoding modified GP 120 signal sequences
WO2005012535A2 (en) * 2003-08-01 2005-02-10 Phytovation B.V. Method for producing life attenuated viruses and use of viral particles thus produced.
CN111701016A (zh) * 2020-06-28 2020-09-25 张全志 逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5848794A (en) * 1993-02-05 1994-08-29 Regents Of The University Of California, The Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use

Also Published As

Publication number Publication date
ZA200100941B (en) 2002-02-04
CA2339850C (en) 2011-10-04
AP2001002076A0 (en) 2001-03-31
PT1105498E (pt) 2009-08-13
DE69940886D1 (en) 2009-06-25
EP1105498A1 (en) 2001-06-13
CN1318104A (zh) 2001-10-17
CA2339850A1 (en) 2000-02-24
CN1206355C (zh) 2005-06-15
WO2000009703A1 (en) 2000-02-24
ATE431415T1 (de) 2009-05-15
EP1105498B1 (en) 2009-05-13
OA11598A (en) 2004-07-30
KR100689249B1 (ko) 2007-03-08
ES2327300T3 (es) 2009-10-27
AU5274099A (en) 2000-03-06
KR20010072436A (ko) 2001-07-31
AP1561A (en) 2006-02-01

Similar Documents

Publication Publication Date Title
NO20003303L (no) Vaksine
NO20014325D0 (no) Vaksine
NO20006191D0 (no) Vaksine
DE69800383D1 (de) Influenza Vaccine
NO20004758L (no) Vaksinesammensetning
NO20031483L (no) Vaksine
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
ATE490327T1 (de) Impfstoffzusammensetzung
IS6040A (is) Valdekoxib efnablöndur
NO20024172L (no) Vaksine
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763D0 (no) Vaksine
EE200200150A (et) Preparaat
GB9826069D0 (en) HIV vaccine
NO20005599D0 (no) Vaksine
ATE431415T1 (de) Hiv impfstoff
DE29807640U1 (de) Arbeitsgerät
ITMI981384A0 (it) Vaccino per hiv
DE50009295D1 (de) Vernetzerfreie zubereitungen
ITMI992410A0 (it) Vaccino per hiv
NO20002213D0 (no) Babesia vaksine
FIU990234U0 (fi) Vuoka